Literature DB >> 40181

Red cell oxygen affinity, hemoglobin type, 2,3-diphosphoglycerate, and pH as a function of fetal development.

H Bard, F Teasdale.   

Abstract

Studies were carried out on fresh cord blood obtained at delivery from nonstressed normal fetuses ranging from 24 to 42 weeks of gestation, to determine the relationship of 2,3-diphosphoglycerate (DPG), the intracellular red cell and extracellular pH, and the proportions of adult and fetal hemoglobin in regulating the position of fetal red cell oxygen affinity in utero. There was a significant positive correlation between P50 and gestational age (r = .62, P less than .001), the linear regression increased from 17.8 to 22.5 mm Hg. There was also a significant positive correlation between P50 and the percentage of adult type hemoglobin (HbA) (r = .67, P less than .001). In contrast gestational age had no effect of 2,3-DPG levels, the mean and SD was 14.86 +/- 2.04 mol/gm of Hb or delta pH between plasma and red cell, the mean was 0.187 +/- SD 0.032. However, there was a significant negative correlation between the intraerythrocyte hydrogen ion concentration and DPG level (r = .5, P less than .025). It is concluded therefore that the decrease in fetal oxygen affinity as gestation progresses is related mainly to the increase in the amount of HbA and the levels of DPG or delta pH between plasma and red cells are not a function of gestational age.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40181

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  2 in total

1.  A comparison of E15.5 fetus and newborn rat serum proteomes.

Authors:  Lilong Wei; Lulu Jia; Lisi Zhu; Sucan Ma; Dan Zhang; Chen Shao; Wei Sun; Youhe Gao
Journal:  Proteome Sci       Date:  2012-11-07       Impact factor: 2.480

2.  Effects of Sodium Phosphate Loading on Aerobic Power and Capacity in off Road Cyclists.

Authors:  Milosz Czuba; Adam Zajac; Stanislaw Poprzecki; Jaroslaw Cholewa; Scott Woska
Journal:  J Sports Sci Med       Date:  2009-12-01       Impact factor: 2.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.